Go Pro

Octopus Titan VCT (OTV2) Competitors

Octopus Titan VCT logo
GBX 16 -1.50 (-8.57%)
As of 07/14/2026 11:48 AM Eastern

OTV2 vs. BPCR, SDP, GSS, VEIL, and GROW

Should you buy Octopus Titan VCT stock or one of its competitors? MarketBeat compares Octopus Titan VCT with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Octopus Titan VCT include BioPharma Credit (BPCR), Schroder Investment Trust - Schroder AsiaPacific Fund (SDP), Genesis Emerging Markets Fund (GSS), Vietnam Enterprise (VEIL), and Molten Ventures (GROW). These companies are all part of the "asset management" industry.

How does Octopus Titan VCT compare to BioPharma Credit?

Octopus Titan VCT (LON:OTV2) and BioPharma Credit (LON:BPCR) are both small-cap financial services companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk.

0.1% of Octopus Titan VCT shares are owned by institutional investors. Comparatively, 31.3% of BioPharma Credit shares are owned by institutional investors. 0.0% of Octopus Titan VCT shares are owned by company insiders. Comparatively, 0.1% of BioPharma Credit shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

BioPharma Credit has higher revenue and earnings than Octopus Titan VCT. Octopus Titan VCT is trading at a lower price-to-earnings ratio than BioPharma Credit, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Octopus Titan VCT-£86.81M-3.04-£173.99M-£5.50N/A
BioPharma Credit£132.06M0.08£10.42B£11.400.08

Octopus Titan VCT pays an annual dividend of GBX 0.50 per share and has a dividend yield of 3.1%. BioPharma Credit pays an annual dividend of GBX 7 per share and has a dividend yield of 726.1%. Octopus Titan VCT pays out -9.1% of its earnings in the form of a dividend. BioPharma Credit pays out 61.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Octopus Titan VCT has a net margin of 238.29% compared to BioPharma Credit's net margin of 92.62%. BioPharma Credit's return on equity of 11.29% beat Octopus Titan VCT's return on equity.

Company Net Margins Return on Equity Return on Assets
Octopus Titan VCT238.29% -15.45% -14.38%
BioPharma Credit 92.62%11.29%4.98%

Octopus Titan VCT has a beta of -0.09, suggesting that its stock price is 109% less volatile than the broader market. Comparatively, BioPharma Credit has a beta of 0.22095597, suggesting that its stock price is 78% less volatile than the broader market.

In the previous week, Octopus Titan VCT's average media sentiment score of 0.00 equaled BioPharma Credit'saverage media sentiment score.

Company Overall Sentiment
Octopus Titan VCT Neutral
BioPharma Credit Neutral

Summary

BioPharma Credit beats Octopus Titan VCT on 11 of the 13 factors compared between the two stocks.

How does Octopus Titan VCT compare to Schroder Investment Trust - Schroder AsiaPacific Fund?

Octopus Titan VCT (LON:OTV2) and Schroder Investment Trust - Schroder AsiaPacific Fund (LON:SDP) are both small-cap financial services companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, media sentiment, earnings, analyst recommendations and dividends.

Octopus Titan VCT has a net margin of 238.29% compared to Schroder Investment Trust - Schroder AsiaPacific Fund's net margin of 95.12%. Schroder Investment Trust - Schroder AsiaPacific Fund's return on equity of 20.01% beat Octopus Titan VCT's return on equity.

Company Net Margins Return on Equity Return on Assets
Octopus Titan VCT238.29% -15.45% -14.38%
Schroder Investment Trust - Schroder AsiaPacific Fund 95.12%20.01%-1.73%

0.1% of Octopus Titan VCT shares are owned by institutional investors. Comparatively, 17.2% of Schroder Investment Trust - Schroder AsiaPacific Fund shares are owned by institutional investors. 0.0% of Octopus Titan VCT shares are owned by insiders. Comparatively, 0.2% of Schroder Investment Trust - Schroder AsiaPacific Fund shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Schroder Investment Trust - Schroder AsiaPacific Fund has higher revenue and earnings than Octopus Titan VCT. Octopus Titan VCT is trading at a lower price-to-earnings ratio than Schroder Investment Trust - Schroder AsiaPacific Fund, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Octopus Titan VCT-£86.81M-3.04-£173.99M-£5.50N/A
Schroder Investment Trust - Schroder AsiaPacific Fund£191.10M5.33£121.21M£135.645.99

Octopus Titan VCT has a beta of -0.09, suggesting that its share price is 109% less volatile than the broader market. Comparatively, Schroder Investment Trust - Schroder AsiaPacific Fund has a beta of 0.718, suggesting that its share price is 28% less volatile than the broader market.

Octopus Titan VCT pays an annual dividend of GBX 0.50 per share and has a dividend yield of 3.1%. Schroder Investment Trust - Schroder AsiaPacific Fund pays an annual dividend of GBX 13 per share and has a dividend yield of 1.6%. Octopus Titan VCT pays out -9.1% of its earnings in the form of a dividend. Schroder Investment Trust - Schroder AsiaPacific Fund pays out 9.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Octopus Titan VCT is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Schroder Investment Trust - Schroder AsiaPacific Fund had 1 more articles in the media than Octopus Titan VCT. MarketBeat recorded 1 mentions for Schroder Investment Trust - Schroder AsiaPacific Fund and 0 mentions for Octopus Titan VCT. Schroder Investment Trust - Schroder AsiaPacific Fund's average media sentiment score of 1.08 beat Octopus Titan VCT's score of 0.00 indicating that Schroder Investment Trust - Schroder AsiaPacific Fund is being referred to more favorably in the news media.

Summary

Schroder Investment Trust - Schroder AsiaPacific Fund beats Octopus Titan VCT on 12 of the 15 factors compared between the two stocks.

How does Octopus Titan VCT compare to Genesis Emerging Markets Fund?

Genesis Emerging Markets Fund (LON:GSS) and Octopus Titan VCT (LON:OTV2) are both small-cap asset management industry companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk.

Genesis Emerging Markets Fund pays an annual dividend of GBX 0.17 per share. Octopus Titan VCT pays an annual dividend of GBX 0.50 per share and has a dividend yield of 3.1%. Genesis Emerging Markets Fund pays out 0.1% of its earnings in the form of a dividend. Octopus Titan VCT pays out -9.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Octopus Titan VCT is clearly the better dividend stock, given its higher yield and lower payout ratio.

0.1% of Octopus Titan VCT shares are owned by institutional investors. 0.0% of Octopus Titan VCT shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Genesis Emerging Markets Fund's average media sentiment score of 0.00 equaled Octopus Titan VCT'saverage media sentiment score.

Company Overall Sentiment
Genesis Emerging Markets Fund Neutral
Octopus Titan VCT Neutral

Genesis Emerging Markets Fund has higher revenue and earnings than Octopus Titan VCT. Octopus Titan VCT is trading at a lower price-to-earnings ratio than Genesis Emerging Markets Fund, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Genesis Emerging Markets Fund£250.40M0.00N/A£140.70N/A
Octopus Titan VCT-£86.81M-3.04-£173.99M-£5.50N/A

Octopus Titan VCT has a net margin of 238.29% compared to Genesis Emerging Markets Fund's net margin of 0.00%. Genesis Emerging Markets Fund's return on equity of 0.00% beat Octopus Titan VCT's return on equity.

Company Net Margins Return on Equity Return on Assets
Genesis Emerging Markets FundN/A N/A N/A
Octopus Titan VCT 238.29%-15.45%-14.38%

Summary

Genesis Emerging Markets Fund and Octopus Titan VCT tied by winning 5 of the 10 factors compared between the two stocks.

How does Octopus Titan VCT compare to Vietnam Enterprise?

Octopus Titan VCT (LON:OTV2) and Vietnam Enterprise (LON:VEIL) are both small-cap financial services companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, dividends, earnings, risk, valuation and profitability.

Octopus Titan VCT has a net margin of 238.29% compared to Vietnam Enterprise's net margin of 96.37%. Vietnam Enterprise's return on equity of 19.70% beat Octopus Titan VCT's return on equity.

Company Net Margins Return on Equity Return on Assets
Octopus Titan VCT238.29% -15.45% -14.38%
Vietnam Enterprise 96.37%19.70%-7.53%

Vietnam Enterprise has higher revenue and earnings than Octopus Titan VCT. Octopus Titan VCT is trading at a lower price-to-earnings ratio than Vietnam Enterprise, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Octopus Titan VCT-£86.81M-3.04-£173.99M-£5.50N/A
Vietnam Enterprise£369.38M2.75-£4.24M£208.003.56

Octopus Titan VCT has a beta of -0.09, suggesting that its share price is 109% less volatile than the broader market. Comparatively, Vietnam Enterprise has a beta of 0.44, suggesting that its share price is 56% less volatile than the broader market.

0.1% of Octopus Titan VCT shares are owned by institutional investors. Comparatively, 37.0% of Vietnam Enterprise shares are owned by institutional investors. 0.0% of Octopus Titan VCT shares are owned by company insiders. Comparatively, 0.2% of Vietnam Enterprise shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Octopus Titan VCT's average media sentiment score of 0.00 equaled Vietnam Enterprise'saverage media sentiment score.

Company Overall Sentiment
Octopus Titan VCT Neutral
Vietnam Enterprise Neutral

Summary

Vietnam Enterprise beats Octopus Titan VCT on 10 of the 11 factors compared between the two stocks.

How does Octopus Titan VCT compare to Molten Ventures?

Molten Ventures (LON:GROW) and Octopus Titan VCT (LON:OTV2) are both small-cap financial services companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.

Molten Ventures has a beta of 1.307, meaning that its share price is 31% more volatile than the broader market. Comparatively, Octopus Titan VCT has a beta of -0.09, meaning that its share price is 109% less volatile than the broader market.

Octopus Titan VCT has a net margin of 238.29% compared to Molten Ventures' net margin of 75.09%. Molten Ventures' return on equity of 9.21% beat Octopus Titan VCT's return on equity.

Company Net Margins Return on Equity Return on Assets
Molten Ventures75.09% 9.21% -3.46%
Octopus Titan VCT 238.29%-15.45%-14.38%

Molten Ventures presently has a consensus price target of GBX 638.67, suggesting a potential upside of 4.80%. Given Molten Ventures' stronger consensus rating and higher possible upside, equities research analysts plainly believe Molten Ventures is more favorable than Octopus Titan VCT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Molten Ventures
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Octopus Titan VCT
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Molten Ventures has higher revenue and earnings than Octopus Titan VCT. Octopus Titan VCT is trading at a lower price-to-earnings ratio than Molten Ventures, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Molten Ventures£148M7.08-£33.58M£69.008.83
Octopus Titan VCT-£86.81M-3.04-£173.99M-£5.50N/A

In the previous week, Molten Ventures' average media sentiment score of 0.00 equaled Octopus Titan VCT'saverage media sentiment score.

Company Overall Sentiment
Molten Ventures Neutral
Octopus Titan VCT Neutral

41.0% of Molten Ventures shares are owned by institutional investors. Comparatively, 0.1% of Octopus Titan VCT shares are owned by institutional investors. 1.6% of Molten Ventures shares are owned by company insiders. Comparatively, 0.0% of Octopus Titan VCT shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Molten Ventures beats Octopus Titan VCT on 13 of the 14 factors compared between the two stocks.

Get Octopus Titan VCT News Delivered to You Automatically

Sign up to receive the latest news and ratings for OTV2 and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OTV2 vs. The Competition

MetricOctopus Titan VCTAsset Management IndustryFinancial SectorLON Exchange
Market Cap£263.72M£2.50B£6.22B£2.85B
Dividend Yield8.29%6.00%5.24%6.12%
P/E Ratio-2.9162.7729.67368.59
Price / Sales-3.041,843.381,177.0784,769.40
Price / Cash5.4160.50117.4027.89
Price / Book0.291.326.537.56
Net Income-£173.99M£265.96M£1.13B£5.89B
7 Day Performance-8.57%0.01%0.04%0.46%
1 Month Performance-11.11%-0.08%0.05%-1.09%
1 Year Performance-50.00%7.68%15.52%62.59%

Octopus Titan VCT Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OTV2
Octopus Titan VCT
N/AGBX 16
-8.6%
N/A-50.0%£263.72M-£86.81MN/A30
BPCR
BioPharma Credit
N/AGBX 0.96
+0.3%
N/A+9.1%£1.07B£132.06M0.08N/A
SDP
Schroder Investment Trust - Schroder AsiaPacific Fund
N/AGBX 846
-0.1%
N/A+41.3%£1.06B£191.10M6.24N/A
GSS
Genesis Emerging Markets Fund
N/AN/AN/AN/A£1.06B£250.40M6.181,626
VEIL
Vietnam Enterprise
N/AGBX 773.94
+0.9%
N/A+11.1%£1.05B£369.38M3.72N/A

Related Companies and Tools


This page (LON:OTV2) was last updated on 7/16/2026 by MarketBeat.com Staff.
From Our Partners